-
Mashup Score: 8
A retrospective analysis shows that trifluridine/tipiracil with or without bevacizumab given biweekly was favorable in those with colorectal cancer.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 5
Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role in colon cancer. Researchers also showed how this mutation could be targeted therapeutically.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
A recent study by Fox Chase researchers identifies a gene mutation that may serve as a promising target for highly personalized treatments in colorectal cancer. Read more from Jonathan Chernoff, MD, PhD, Cancer Center Director & senior author on the study: https://t.co/Qozv4XJ4di
-
-
Mashup Score: 2Fox Chase Cancer Center Dietitian, Researchers Create Pilot Program For Educating Clinicians on Chemosensory Dysfunction - 2 day(s) ago
A pilot program developed to educate healthcare providers about patient chemosensory dysfunction significantly improved providers’ knowledge and confidence in providing support to patients, according to a recent publication on the program from clinicians and researchers at Fox Chase Cancer Center.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
Fox Chase clinicians and researchers have launched a new pilot program aimed at equipping oncology clinicians with nutrition knowledge to better support cancer patients. Read more from 1 of the lead authors on the study Kara Stromberg, MS, RD, LDN, CDCES: https://t.co/3PNGmHdkGr
-
-
Mashup Score: 2
The Philadelphia Conquering Cancer Coalition aims to remove barriers and improve communication and collaboration between various health centers and community organizations.
Source: whyy.orgCategories: General Medicine NewsTweet-
Fox Chase Cancer Center is proud to be part of the Conquering Cancer Coalition of Greater Philadelphia, uniting with local leaders and healthcare partners to improve cancer prevention, treatment, and equity in our communities: https://t.co/awxBmDS2Pi
-
-
Mashup Score: 0Fox Chase Cuts the Ribbon on the Oncology Satellite Pharmacy - 3 day(s) ago
At Fox Chase Cancer Center, every advancement begins with a single focus: the patient. On Friday, June 13, 2025, Fox Chase officially opened the new Oncology Satellite Pharmacy—a facility built to dramatically increase the speed and safety with which life-saving medications reach patients.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
Fox Chase just celebrated the ribbon cutting of its new Oncology Satellite Pharmacy! This important addition will help ensure patients have easier, faster access to the medications they need, all while improving safety, care coordination, and convenience: https://t.co/koKacWa7xy https://t.co/Oy3QVH1yRA
-
-
Mashup Score: 23Dr. Jeffrey Farma Named the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology at Fox Chase Cancer Center - 4 day(s) ago
Jeffrey Farma, MD, FACS, Chair and Professor in the Department of Surgery, was honored today for his appointment to the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology at Fox Chase Cancer Center.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
Congratulations to @JeffreyFarma, MD, FACS, Chair and Professor in the Department of Surgery, who was recently honored for his appointment to the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology at Fox Chase Cancer Center: https://t.co/oyreymAXuY
-
-
Mashup Score: 15Improving the Alliance Between Oncologists and Primary Care Providers: A Call for Collaborative Action - 4 day(s) ago
Experts and patients alike would agree that navigating the current fragmented U.S. health-care system is not an easy task. One component of that disconnection may center on the relationship between on…
Source: ascopost.comCategories: General Medicine NewsTweet-
Andrea Porpiglia, MD, of Fox Chase Cancer Center, emphasizes the importance of stronger collaboration between oncologists and primary care providers to improve patient care across the cancer journey. Read more in The ASCO Post: https://t.co/hVh2Rv4iXp #Oncology @AndreaSurg1
-
-
Mashup Score: 11Fox Chase Cancer Center Bestows Stanley P. Reimann Honor Award Upon Renowned Biologist Andrea Califano - 21 day(s) ago
Andrea Califano, Dr, a leader in the field of systems biology, was recognized today at Fox Chase Cancer Center with the Stanley P. Reimann Honor Award, the center’s highest distinction.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
Fox Chase is proud to present Dr. Andrea Califano with the Stanley P. Reimann Honor Award—the center’s highest distinction. Dr. Califano joins a list of 18 individuals who have received the award since 1974. Congratulations on this well-deserved honor: https://t.co/DW3d5OlzRc
-
-
Mashup Score: 8Review Paper By Fox Chase Cancer Center Scientists Recounts History of DNA Amplification Research - 21 day(s) ago
The process of DNA amplification, the increase in the number of copies of a gene, has long been known to play a role in cancer and other diseases. More recently, research has focused on regulating this process for therapeutic benefit. Now, scientists at Fox Chase Cancer Center have “connected the dots” with a new paper that reviews decades of research and DNA amplification discoveries.
Source: www.foxchase.orgCategories: General Medicine NewsTweet-
How did DNA amplification shape cancer research? Scientists at Fox Chase Cancer Center explore its evolution and impact in a new review paper. Read more from corresponding author on the review, Johnathan Whetstine, PhD, @CeiFccc @WhetstineLab: https://t.co/cIfOhk5cuh
-
-
Mashup Score: 8
Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday’s Phillies’ game as a part of Strike Out Cancer Night.
Source: www.cbsnews.comCategories: General Medicine NewsTweet-
Josh Breen, a stage‑3 melanoma survivor from Philadelphia and a Fox Chase patient, threw out the first pitch at the @Phillies “Strike Out Cancer” night on June 10th. At just 30, his journey highlights breakthroughs in cancer care for young adults: https://t.co/vTywCvGpic
-
A retrospective analysis shows that trifluridine/tipiracil with or without bevacizumab given biweekly was favorable in those with colorectal cancer. Read more from Fox Chase's @ChrisCannMD: https://t.co/mk4ahseeWv